Common Medications and Laboratory test for Post-op Open Heart Patients

Slides:



Advertisements
Similar presentations
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 8 Cardiovascular.
Advertisements

Hemodynamic Monitoring
Severe Sepsis Initial recognition and resuscitation
SHOCK.
Common Cardiovascular Drugs
Cardiovascular Medications PICU Resident Talk Stanford School of Medicine Pediatric Critical Care Medicine June 2010.
Cardiac Arrhythmia. Cardiac Arrhythmia Definition: The pumping action of the heart is coordinated by an electrical system within the heart tissue.
1 Cardiac Pathophysiology Part B. 2 Heart Failure The heart as a pump is insufficient to meet the metabolic requirements of tissues. Can be due to: –
Bio-Med 350 Normal Heart Function and Congestive Heart Failure.
Cardiac drugs Cardiac glycoside Cardiac glycosides are the most effective drugs for treatment of C.H.F. Digitoxins are plant alkaloids. They increase myocardial.
Cardiovascular management
Drugs for Heart Failure
Drugs for CCF Heart failure is the progressive inability of the heart to supply adequate blood flow to vital organs. It is classically accompanied by significant.
CONCEPTS OF NORMAL HEMODYNAMICS AND SHOCK
Shock Amr Mohsen.
Shock William Lawson, MD Division of Allergy, Pulmonary, and Critical Care Medicine.
CARDIOVASCULAR CARE of the OUTPATIENT Diane M. Enzweiler, MSN, ANP-BC St. Elizabeth Physicians: Heart and Vascular.
Post-Operative Care of Congenital Heart Disease Patients A brief pediatrics perspective.
Drugs for Congestive Heart Failure
Thrombolytic drugs BY :DR. ISRAA OMAR.
Role of Factor Concentrates in Perioperative Coagulopathies Dr Neville Gibbs Department of Anaesthesia Sir Charles Gairdner Hospital.
Heart failure Dr Rafat Mosalli. Objectives Definition Definition Pathophysiology Pathophysiology Age specific Causes Age specific Causes Clinical pictures.
Frank-Starling Mechanism
PROF. AZZA El-Medany Department of Pharmacology OBJECTIVES At the end of lectures the students should Describe the different classes of drugs used for.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 21 Positive Inotropic Drugs.
PICU Resident Talk Stanford School of Medicine Pediatric Critical Care Medicine June 2014.
Cardiogenic Shock Dr. Belal Hijji, RN, PhD October 12 & 15, 2011.
Copyright 2008 Society of Critical Care Medicine
Giving our patients the best chance to survive shock Erik Diringer, DO Intensivist – Kenmore Mercy Hospital.
Thank you Suanne Daves, MD
Systolic Versus Diastolic Failure. Forms of Heart Failure Sytolic Failure Inability of the ventricle to contract normally and expel sufficient blood Inadequate.
 Introduction  Classification of inotropes  Postoperative myocardial dysfunction.  Choice of inotrope  Indications in specific settings.
SHK 1 ® Diagnosis and Management of Shock SHK 1 ®.
Angina pectoris Sudden,severe,pressing chest pain starting substernal &radiate to left arm & neck. Due to imbalance between myocardium oxygen requirement.
Interventions for Clients in Shock. Shock Can occur when any part of the cardiovascular system does not function properly for any reason Can occur when.
1 Shock. 2 Shock refers to an abnormality of the circulatory system in which there is inadequate tissue perfusion due to a relatively or absolutely inadequate.
Instructions for using this template.
PHARMACOLOGIC THERAPY  Standard First-Line Therapies Angiotensin-Converting Enzyme Inhibitors (ACEI) β Blockers Diuretics Digoxin  Second line Therapies.
Adult and Pediatric Emergency Drugs
Heart Failure  Dfinition:  Clinical features  Underlying causes of HF include Arteriosclerotic heart disease, MI, hypertensive heart disease, valvular.
N Engl J Med 2010;362: R3 CHAE JUNGMIN/ Prof KIM MYENGGON.
Drug acting on the Heart Heart failure. Lecture objectives At the end of the this lecture, the student will able to: Describe basic anatomy of the heart.
Result from any structural or functional cardiac disorder that impairs the ability of the ventricle to fill with or eject blood to meet the body's metabolic.
Vasopressors and Inotropes Critical Care Lecture Series.
CODE BLUE MANAGEMENT DRUG THERAPY
Heart Failure NURS 241 Chapter 35 (p.797).
Drugs Used to Treat Heart Failure
Drugs used for Congestive Heart Failure
Drugs for Hypertension
Drug acting on the Heart
Circulatory shock.
Drugs for Heart Failure
Formative Test.
Cardiovascular Support in ICU
Treatment of Congestive Heart Failure
Maya Govender Practice Educator CTICU FCCNC – 25th October 2017
Inotropes & Vasopressors
Traditional parenteral antihypertensive treatment
Hypertension (High Blood Pressure)
Chapter 15 Shock and Multiple Organ Dysfunction Syndrome
Maya Govender Practice Educator CTICU FCCNC – 30th January 2018
CRITICAL CARE TRANSPORT MEDICATIONS
Antianginal Drugs.
Anti hypertensive Drugs
Drugs Acting on the Heart
CARDIOVASCULAR AGENTS
Recent advances – levosimendan
Cardiovascular System
Plasma expanders Dept. of Pharmacology CIPS.
Presentation transcript:

Common Medications and Laboratory test for Post-op Open Heart Patients Always remember….

Objectives Understand use of specific class of medications and their impact upon the cardiac system. Identify one indication and one contraindication for medications based upon patient needs. Identify laboratory testing and one corrective measure for specific abnormality. Understand the variants between POCT versus direct laboratory values and the impact upon the bedside treatment

Dilators, Constrictors, et al in between Medications Dilators, Constrictors, et al in between

Inotropes Used to alter force of energy creation Can be either ‘negative’ or ‘positive’ in nature Tend to like the ‘positive’ effects seen Always deliver centrally due to adverse effects to tissue May alter laboratory levels, i.e. Calcium Glucose diabetics

Inotropes - Drugs Dopamine Dobutamine Epinepherine Norepinepherine Milrinone Calcium Prostaglandins

Inotropes – effects (good) Increase cardiac output Increase systolic blood pressure Increase urinary output Improvement in contractility will augment cardiac output Rates calculated in microgram/kilogram/minute or micrograms/minute (usually first one is done)

Side effects of inotropic support Tachyarrhythmias Elevated glucose levels Anxiety Small vessel ischemia Kidney insufficiency

Phosphodiesterase inhibitors Isolated in rats brain in 1972 Further studies into 1977 brought them to light for use in humans Non-selective and selective PDE-3 or Milrinone places effect upon cAMP and calcium activation increase in CO decrease in SVR/PVR half-life longer than straight inotropic cousins

PDE inhibitor S/E Kidney dysfunction Considered proarrhythmic Bronchospasms Metabolic derangements potassium

Vasopressors Help with augmenting SVR and supporting blood pressure Majority are considered alpha-agonist with neosynepherine considered a pure alpha Some medications that are inotropes are used in the vasopressor avenue also, Levophed which has both properties Caution with use, may impact small vessel ischemia so patient assessment and evaluation key points

Hormone peptide - Vasopressin Increase vascular resistance, hence increasing arterial blood pressure Compensatory mechanism in shock states Does not increase myocardial oxygen demand as do the other inotropic agents Usually last line drug

Prostoglandins - Flolan Help to control vascular tone Influence sodium excretion Influence upon RAAS system Usually given in nebulized therapy In the presentation of right sided dysfunction 2/2 to pulmonary resistance issues (pulmonary HTN, ARDS, etc) costly

Antiarrhythmics Amiodarone Primarily seen for control and alleviation of atrial fibrillation Very long half life, to some extent indeterminate Can act as ‘chemical’ defibrillation agent so must be used cautiously Long term side effects – lungs, eyes, thyroid, GI

Antiarrhythmics - continued Digoxin Atrial fib impact Rate control predominantly Does have inotropic effects, positive to LV Requires loading dosage Levels should be monitored to avoid side effects

Antiarrhythmics - continued Cardizem Atrial fib rate control Will have some degree impact upon blood pressure Titrated to attainable heart rate, usually <110 Can quickly cause bradycardia

Antiarrhythmic medication side effects Proarrhythmic potential Bradycardia Hypotension Mentation alterations n/v Visual disturbances

Factor VIIa (recombinant) Used in face of coagulopathy not responsive to other means Direct action on reducing fibrinolysis Usually given in conjunction with cryoprecipitate factors Costly

Protamine sulfate Reversal for heparin Primarily given after completion of cardiopulmonary bypass Due to potential rebound heparin effects, can be given at bedside Allergy to fish contraindication, effects can be very dramatic 1 mg for every 100 units normal dosage regimen

Blood Products Platelets Fresh frozen plasma Cryoprecipitate Bleeding issues Low counts Fresh frozen plasma volume Cryoprecipitate Factor deficiencies

Labs commonly seen Hemoglobin/hematocrit Platelet count Basic metabolic profile Arterial blood gas Ionized calcium level Magnesium Lactic acid level Heparin antibody

Common labs – continued Coagulation profile Blood glucose ACT